Form 4: Disc Medicine's Chief Medical Officer Sells Shares Under Pre-Arranged Trading Plan

Disc Medicine's Chief Medical Officer, William Jacob Savage, sold 2,996 shares of common stock for $50 per share on June 6, 2025, as part of a pre-established Rule 10b5-1 trading plan.

Summary

• William Jacob Savage, the Chief Medical Officer of Disc Medicine, Inc. (IRON), reported a sale of common stock.
• The transaction involved the disposition of 2,996 shares of common stock.
• The shares were sold at a price of $50 per share.
• The total value of the shares sold amounts to $149,800.
• Following this transaction, Mr. Savage beneficially owns 56,725 shares of common stock directly.
• The sale was executed on June 6, 2025.
• This transaction was conducted pursuant to a Rule 10b5-1 trading plan, which was adopted on January 23, 2025.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While it's an insider sale, the fact that it's under a pre-arranged 10b5-1 plan mitigates negative implications, suggesting a planned liquidity event rather than a reaction to new negative information.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, which indicates a pre-scheduled transaction and enhances transparency, potentially mitigating concerns about opportunistic insider selling.

Negatives

• A Chief Medical Officer selling shares, even under a pre-arranged plan, could be interpreted by some investors as a slight negative signal, although the 10b5-1 plan significantly reduces this implication.
• The transaction reduces the direct ownership stake of a key executive in the company.

Risks

• No specific risks beyond general market perception of insider selling are mentioned in this document.

Future Outlook

NA

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: May observe the insider sale, which could be interpreted differently depending on individual investment philosophies, though the 10b5-1 plan generally reduces concerns about opportunistic selling.

Key Dates

Keywords

Disc Medicine, IRON, Form 4, insider trading, stock sale, Chief Medical Officer, William Jacob Savage, 10b5-1 plan